LIVANOVA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.14 USD | -1.55% |
|
-2.33% | +18.17% |
| May. 01 | LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance | MT |
| May. 01 | Transcript : LivaNova PLC, Q1 2024 Earnings Call, May 01, 2024 |
Presenter SpeechAmit Hazan (Analysts)All right. Good morning, everyone. Hope you can hear me o...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Companyâs next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.
Calendar
2024-06-11
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
62.1
USD
Average target price
69.2
USD
Spread / Average Target
+11.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.17% | 3.36B | |
| -4.82% | 182B | |
| +1.38% | 110B | |
| -2.82% | 68.11B | |
| +0.69% | 50.53B | |
| +8.54% | 44.8B | |
| +2.84% | 40.7B | |
| +20.50% | 32.25B | |
| +1.72% | 26.53B | |
| +15.25% | 25.02B |
- Stock Market
- Equities
- LIVN Stock
- News LivaNova PLC
- Transcript : LivaNova PLC Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-15-2022 10